VASCO Reports Results for Fourth Quarter and Full Year 2017
Feb 21, 2018 21:01 pm UTC| Business
Fourth Quarter Financial Results Q4 Total revenue of $54.5 millionQ4 GAAP operating income of $1.2 millionQ4 GAAP earnings (loss) per share of ($0.65), includes estimated tax reform impact of ($0.70) per shareQ4 Non-GAAP...
Gulfport Energy Corporation Reports Fourth Quarter and Year-End 2017 Results
Feb 21, 2018 21:01 pm UTC| Business
OKLAHOMA CITY, Feb. 21, 2018 -- Gulfport Energy Corporation (NASDAQ:GPOR) (“Gulfport” or the “Company”) today reported financial and operational results for the quarter and year ended December 31, 2017 and provided an...
ECN Capital Schedules Q4-2017 Conference Call
Feb 21, 2018 21:01 pm UTC| Business
TORONTO, Feb. 21, 2018 -- ECN Capital Corp. (TSX:ECN) (“ECN Capital” or “the Company”), one of North America’s leading finance companies, today announced that it intends to file its financial statements and management...
Cerner Implements Surescripts Prescription Price Transparency Functionality Within the EHR
Feb 21, 2018 21:01 pm UTC| Business
KANSAS CITY, Mo., Feb. 21, 2018 -- Cerner, a global leader in health care technology, is collaborating with Surescripts to integrate their Real-Time Prescription Benefit functionality into the Cerner Millennium®...
Capital Southwest Provides Growth Capital to Apollo MedFlight
Feb 21, 2018 21:01 pm UTC| Business
DALLAS, Feb. 21, 2018 -- Capital Southwest Corporation (“Capital Southwest”) (Nasdaq:CSWC), a middle-market lending firm focused on supporting the acquisition and growth of middle market businesses, announced today that...
Martin Midstream Partners Announces 2018 Financial Guidance Conference Call Today
Feb 21, 2018 21:01 pm UTC| Business
KILGORE, Texas, Feb. 21, 2018 -- Martin Midstream Partners will host a conference call announcing its 2018 financial guidance today at 3:30 p.m. Central Time for members of the analyst and investing community and the...
Feb 21, 2018 21:01 pm UTC| Business
Topline data expected in March 2018 from first of three ongoing Phase 2 trials evaluating the myelopreservation benefits of trilaciclib Management to host webcast and conference call today at 4:30 p.m. EST RESEARCH...